reNEW

Market Access

One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.

News

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.